[chart]investorshub.advfn.com/uimage/uploads/2017/6/28/lmzwbrabits.jpg[/chart]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ALKM..NO That is my guess. The Q's won't need audited so I figure a month to get them out.
ALKM give the new auditor's a month to start getting the 10-Q's out.
U got ALKM mixed up with pur* that is center of the earth stock :)
CELZ NEWS 6/20/2019 100+ Patients Treated for Erectile Dysfunction Utilizing Company's Patented CaverStem(R) Stem Cell Procedure with Significant Success Rate and No Adverse Effects Reported
7:50 AM ET 6/20/19 | Dow Jones
General corporate updates and plans for second half of 2019
PHOENIX, June 20, 2019 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTCQB: CELZ), a leading commercial stage biotechnology company focused on Urology, Orthopedics and Neurology using stem cell treatments, today announced business updates and plans for remainder of 2019.
Recent Business Highlights
-- CaverStem(R) Regenerative Stem Cell Procedure for Treatment of Erectile
Dysfunction in Men
-- Healthcare Professional (HCP) Recruitment/Training ongoing with 5 new
facilities coming onboard in the last 60 days and multiple other
locations presently being vetted and scheduled for training.
-- Increasing consumer awareness campaigns utilizing print/digital/radio in
local regions where CaverStem(R) is offered successfully driving patients
into clinic
-- Featured on ABC News as breakthrough technology with potential to help
millions of men -- many additional requests for media currently being
vetted
-- FemCelz(TM) Regenerative Stem Cell Procedure for Treatment of Female
Sexual Dysfunction
-- Soft launch utilizing established CaverStem(R) clinics proving to be
effective commercial strategy
-- 5 additional patients successfully treated in New Mexico within the past
30 days.
-- StemSpine(TM) Regenerative Stem Cell Procedure for Treatment of
Degenerative Disc Disease using the patients own bone marrow derived stem
cells.
-- As previously announced, the StemSpine program is scheduled for a soft
launch in the latter part of 2019. Currently the company continues to
focus its efforts on commercialization of its lead out technologies
CaverStem(R) and FemCelz(TM)
-- AmnioStem(TM)
-- The AmnioStem technology is the use of stem cells from amniotic fluid
which is considered a drug. This process differs significantly from our
other technologies whereupon we use the patients own bone marrow derived
stem cells. This requires a an investigational new drug application
process through the FDA, of which we are highly familiar. We are moving
forward with this program and are pleased with the progress.
A Look Ahead (H2 2019 Plans)
-- Demonstrate Thought Leadership/Scientific Prowess:
-- Submission to scientific peer-reviewed journals to showcase early
clinical data
-- Present at targeted industry conferences
-- Host webinars utilizing our Scientific Advisory Board
-- Continuing to implement our electronic registry so that physicians may
share information with one another under strict HIPAA compliance.
-- CaverStem(R)/FemStem(TM) Centers of Excellence
-- Continue to onboard new CaverStem(R) and FemCelz(TM) centers strategic
locales around the world
-- Optimize training program to ensure new HCPs are equipped to succeed
-- Provide ongoing support to address any questions utilizing peer to peer
network
-- Provide continued marketing in specific locations
-- Consumer Awareness
-- Expand online marketing campaign to create human connection at digital
scale
-- Seek strategic product placement partnerships (i.e. The Doctors)
-- Develop a comprehensive referral program to turn existing happy clients
into evangelists
"We are at an inflection point in our efforts to establish Creative Medical Technology Holdings, Inc. as the pre-eminent leader in unlocking the full potential of stem cells for medical breakthroughs in the areas of Urology, Orthopedics and Neurology," said Timothy Warbington, President and CEO of Creative Medical Technology Holdings Inc. "We are thrilled by the support of the medical community for our leading CaverStem(R) procedure and energized by the success stories that are pouring in from around the world from men whose lives have been drastically improved as a direct result of our products. We remain steadfast in our commitment to accelerate adoption of CaverStem(R) and utilize our existing relationships with HCPs to introduce FemCelz(TM) to help the growing number of women that experience sexual dysfunction."
Dr. Elias Said, MD, FACEP added, "As a medical doctor for over 30 years, rarely have I seen a technology that has the potential to radically improve lives more than CaverStem(R) and FemStem(TM). In addition to becoming a leading provider of the technologies out of my Regenerative Medicine Health location in Las Cruces, NM, I am proud to partner with Creative Medical Technology Holdings, Inc. to serve as a trainer to onboard other HCPs interested in establishing their own practices around the country. Most recently, I had the pleasure of training two locations in the Greater Los Angeles area."
About Erectile Dysfunction
Erectile dysfunction (ED) is characterized by the lack of ability to achieve and maintain penile erection for intercourse. Methods used to quantify ED include the Erectile Function Visual Analog Scale (EF-VAS) and the International Index of Erectile Function (IIEF-5), however clinically it is primarily diagnosed based on symptomology. In our aging society, ED is becoming an increasing problem. According to one study 39% of men at age 40 experience symptoms of ED, whereas by age 70 the incidence rises to 67%. In this latter age group, it is believed that 50-85% of ED cases are associated with hypertension, diabetes, cardiovascular disease and dyslipidemia. Overall, it is estimated that 10-30 million Americans suffer from this condition.
About Creative Medical Technology Holdings
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company specializing in stem cell technology in the fields of urology, neurology and orthopedics and trades on the OTCQB under the ticker symbol CELZ. For further information about the company, please visit www.creativemedicaltechnology.com.
Forward Looking Statements
OTC Markets has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming clinical trials and laboratory results, marketing efforts, funding, etc. Forward-looking statements address future events and conditions and, therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at www.sec.gov.
Creativemedicaltechnology.com
Caverstem.com
Femcelz.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/100-patients-treated-for-erectile-dysfunction-utilizing-companys-patented-caverstem-stem-cell-procedure-with-significant-success-rate-and-no-adverse-effects-reported-300871832.html
SOURCE Creative Medical Technology Holdings, Inc.
/CONTACT: Timothy Warbington, CEO, 480-789-9939
/Web site: http://creativemedicaltechnology.com
> Dow Jones Newswires
June 20, 2019 07:50 ET (11:50 GMT)
CELZ...Detailed Description:
Erectile dysfunction (ED) is characterized by abnormalities of the vascular system; most commonly, venous leakage (or veno-occlusive dysfunction) resulting from loss of integrity of the surrounding corporal smooth muscle. In the penile vascular system, the corporal smooth muscle is responsible for trapping the blood delivered to the corpora cavernosa via the arterial system. In men who develop ED at an early age, loss of smooth muscle mass, rather than arterial dysfunction, is believed to be the major culprit in the inability to maintain or sustain erections.
Bone marrow is enriched for cells with regenerative potential, including mesenchymal stem cells, which accelerate healing of damaged tissue. The possibility of using bone marrow cells in the treatment of ED is enticing since stem/progenitor cell populations are known to secrete various growth factors, possess anti-inflammatory activities, and can differentiate into cells of the penile architecture.
This study will evaluate safety and efficacy of autologous bone marrow mononuclear cells concentrated by a closed system device and injected intra-cavernously in 20 patients aged 18 to 40 years of age diagnosed with erectile dysfunction with low dose 30 cc or high dose 60 cc. Safety and efficacy will be evaluated at baseline (prior to treatment) and at 1,3,6 and 12-month follow up visits. The study will determine whether injection of bone marrow cells intra-cavernously is a clinically feasible, safe and reproducible approach for treating erectile dysfunction.
ALKM...Ya only 91k sell volume.
https://ih.advfn.com/stock-market/USOTC/alkame-holdings-inc-pn-ALKM/trades
GRDO Shares held tight! No Sellers. :)
ALKM HaHa now 5 mil thinner. :)
GRDO Lookin Good. Won't be long now. :)
Banteks Howco Distributing Awarded $825,000 Contract from the Department of Defense
8:32 AM ET 6/13/19 | Dow Jones
Three-Year Contract with Two Option Years (Up to 5 Years Total)
PINE BROOK, NJ / ACCESSWIRE / June 13, 2019 / Bantek, Inc. (OTC PINK: BANT) ("Bantek" or the"Company"), a distributor of products to the U.S. Government, an environmental services provider and reseller of drones and drone training, today announced that its Howco Distributing subsidiary has been awarded a contract to supply starters and other supplies to the Department of Defense's (DoD) Defense Logistic Agency Aviation Commodities Division, under a three-year contract that includes two additional option years for a potential total of 5 years and a value of approximately $825K.
Michael Bannon, Bantek's Chief Executive Officer, commented, "This is a wonderful addition to our backlog of DoD related commitments. We look forward to working with our long-term supplier and delivering this additional business."
About Howco Distributing Co.
Howco Distributing, a subsidiary of Bantek, Inc., is a premier supplier of spare and replacement parts to a wide variety of Federal Government agencies, U.S. military prime contractors and commercial customers worldwide. Founded in 1990 and located in Vancouver, Washington, Howco's services encompass bid solicitation, contract management, packaging and logistics for construction, transportation, mining and heavy equipment spare and replacement parts to customers worldwide utilizing a wide variety of supply chain solutions. Howco was the winner of 2017 United States Department of Defense Logistics Agency's Commander's Choice Supplier Award and the 2012 United States Department of Defense Logistics Agency's Bronze Supplier Award.
About Bantek, Inc, Inc.
Bantek, Inc. (OTC PINK: BANT), headquartered in Pine Brook, NJ., consists of three separate divisions. First, through Howco Distributing Co., we sell products primarily to the U.S. Department of Defense. Second, through Drone USA we sell drone programs, which consists of drones, training, COA's and waivers and other drone-related services, to law enforcement, firefighters, security companies, local, state and our US government. Third, we sell insulation jackets, slates, and insulation services to hospitals, universities, and manufacturers.
For additional information about Bantek, Inc. and its businesses, please visit:
www.bantekinc.com
www.droneusainc.com
www.howcodistributing.com
Forward-Looking Statements
Certain statements in this press release may be considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include projections of matters that affect revenue, operating expenses or net earnings; projections of growth; and assumptions relating to the foregoing. Such forward-looking statements are generally qualified by terms such as: "plans, "anticipates," "expects," "believes," or similar words. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or qualified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking information. These factors are discussed in greater detail in our Form 10 filed with the U.S. Securities and Exchange Commission.
Contact Information
IR@bantekinc.com
SOURCE: Bantek, Inc.
View source version on accesswire.com:
https://www.accesswire.com/548633/Banteks-Howco-Distributing-Awarded-825000-Contract-from-the-Department-of-Defense
> Dow Jones Newswires
June 13, 2019 08:32 ET (12:32 GMT)
ALKM... Hemp Lifestyle. This brand not only has signed a multi-year Co-pack Agreement with us, but they themselves have just signed a landmark distribution contract covering four states and 7,000 stores. Way to Go!!
ALKM Nice Green Day. New Auditors and Today's News getting set up for that Moon Trip.
Alkame Holdings, Inc. Corporate Update
10:13 AM ET 6/11/19 | Dow Jones
Alkame Holdings, Inc. Corporate Update
LAS VEGAS, NV / ACCESSWIRE / June 11, 2019 / Alkame Holdings, Inc. (OTC PINK: ALKM), a publicly traded health and wellness technology holding company, is taking this opportunity to provide you, our valued shareholders, with an update on the progress of the Company and provide a current status on our various fronts.
"Dear Shareholders,
The 2016 annual report has now been completed and filed on Form 10-K with the SEC, allowing us an opportunity to announce its completion, and share important events since our last corporate update as we continue our work to bring all our filings current. We value and appreciate the feedback we get from our ALKM family, and this Shareholder Update following an annual 10K report also provides us an opportunity to seek out and address many of the questions and concerns about the current state of our business.
After close of fiscal year 2018 we had started making minor changes regarding our financial team's infrastructure by bringing on a comptroller in the fourth quarter, and we are continuing to make additional changes after our most recent filing. As per our recent 8K filing, we are happy to announce that we have retained a well-respected accounting firm and backed that up against an equally impressive auditing firm, with additional infrastructure changes still to follow. These exciting changes will allow our existing financial team to focus solely on the infrastructure, costing, and manufacturing efficiencies at our Bell Food & Beverage Inc. subsidiary. We are excited about these changes, and we very much look forward to working with our newly appointed PCAOB auditors and accounting firm, who will assist and work expeditiously towards getting our filings current and up to date.
The delays in filing have caused financial strain, we can certainly say we've had our ups and downs. While it has been a challenge, we have risen to the occasion and are moving forward in a big way. We are not making excuses, but this company has certainly had its share of obstacles. First there was the Xtreme acquisition, where the paperwork and their largest deals were generating a loss. Regardless, we saw the potential in the Intellectual Property and the small manufacturing operation in Idaho, even though the bookkeeping needed an overhaul. Next came the hectic time consuming, physical move out of the Xtreme facility to a new and much larger manufacturing facility (Bell) in another state, and the accompanying infrastructure issues that came with it. It took our operations offline for several months to basically set our manufacturing equipment back up, almost starting from scratch. A lot of hard work has been, and is still going on, shoring up the situation at Bell. We are transitioning Bell from a family run business to a corporate run organization with procedures and structure being implemented and put in place. We're just beginning to come out the other side of that, adding equipment, Standard Operating Procedures, compliance, organic status, as well as changing and adding personnel to strengthen the infrastructure that will allow us to grow properly and methodically to reach the Company's full potential, and then expand. At the same time, we are having substantial growing pains from the explosion of the Cannabidiol ("CBD") industry which is still in its infancy. All the while, we continue working to bring our filings current which has also caused significant cash flow constraints on both operations and personnel while we maneuver this rocket ship itching to take off onto a much bigger and healthier direction. There is so much good stuff going on behind the scenes to grow this company, and the potential to be a powerhouse of production is within reach. The only thing, and I literally mean the only thing, holding us back is access to smart growth capital and private equity lines, and a little bit of infrastructure assistance.
Alkame, and its assortment of divisions and subsidiaries have been extremely busy since our last update.
First, in a huge turn of recent events, we would like to officially announce the formation of an Alkame Medical division. These are very exciting times for Alkame, our technology, and the very promising potential within the medical space. This newly created division is exploring, researching and testing for growth opportunities and applications within the medical, and medical / CBD sectors, utilizing its water technology as the base solution and delivery mechanism for both CBD and non-CBD related medicines. We now seek to enter and exploit our technology within the medical sector. Initial thoughts and avenues of interest for ALKM are specifically for IV bags for intravenous therapy. We've had several preliminary (and time consuming) discussions with medical and biotech organizations and groups regarding our IP and the various alliances for the application of our technology in those respected fields. Nothing definitive to report currently but this is a work in progress. This is another application we are excited to potentially apply our water technology to and finally bring to market through a joint venture with industry veterans.
We are also exploring Topical and Trans-Dermal medications or ointments applied to body surfaces such as the skin or mucous membranes to treat ailments via a large range of form factors including creams, foams, gels, lotions, and ointments. We see CBD skincare and especially facial skincare to be a growing sector both domestically and internationally, and feel the timing is right to seek out and explore potential license opportunities with Home and Beauty Aid ("HBA") manufacturers. We are looking to work with one or more companies, to create and bring to market various lines of CBD infused skin care products utilizing our technology which allows for healthier and more nourished skin by utilizing our water as the base solution and providing better absorption.
Our Alkame Pets division is in active discussions with several companies that have expressed an interest in the potential acquisition of our Pawz & Clawz trademarked brand. The brand has both CBD and Non-CBD growth potential. The sale of Pawz & Clawz would be in exchange for a small, retained equity position and our retaining the co-packing contract.
Our Alkame Aquaculture division has recently begun discussions with a potential joint venture partner for a pilot program in Oregon to test the potential for future aquaculture fish farming operations. However, we are still seeking introductions and referrals as we continue to seek the right partner to exploit this application and opportunity, but with the Company's resources fully engaged in current business opportunities, we are not currently being aggressive with this matter.
A "Powered by Alkame Technology" icon is now being featured on the labels of many new products entering the market. Our new icon is specifically being used with client's products that are utilizing Alkame as the base solution, and this form of Co-Branding and Cross-Marketing with various clients continues to thrive, especially in CBD products. A short list of some of our favorite successful brands utilizing the IP are Highdrate, EVERx, Simple, Mary's Mixers, and Black Rain, among others. There are certain clients who are not cross-marketing with us, a prime example of this would be the delicious Pacific Flavor blueberries we are getting ready to pack in July and export to Japan.
Our flagship brand and product, Alkame Water, is not down and out. It has simply had to take a backseat for a while as we focused our efforts on co-packing and cross marketing. We are now in the process re-launching Alkame Water in the near future. We have just partnered with a new distribution partner that will handle online sales of the water and distribution in both case and per bottle quantities. Launch date is expected this summer and we are very excited about re-launching.
Our Bell Food & Beverage, Inc. subsidiary is aggressively growing into a powerhouse, but still has a lot of work to be finished. Bell Food & Beverage is a water-based liquid filling manufacturer doing various products like sauces, salsas and condiments, and a whole plethora of both CBD and non-CBD drink products, filling a nice niche in the CBD manufacturing space. Two years young and with zero marketing, we have grown strictly thru methodical internal efforts and organically.
The addition of our new high-speed cold fill production line took a while to debug but was a wise investment that is starting to see the return. Due to demand, the addition of a second shift on this line is about to begin, as the availability of line time is filling up. We are still planning on adding additional pieces of equipment to increase efficiencies to better service of our clients and reduce cost.
We are looking further down the road and preparing for expansion in both our online presence and with an additional east coast facility. Online marketing and expansion plans and related domains waiting in the wings are cbdcopacker.com, westcoastcopacker.com, eastcoastcopacker.com, and bellcampus.com. We are slowly creating a new Bell Foods International website, bellfoodsintl.com behind the scenes, but that is currently taking a back seat to other priorities. The sites shopping cart is in the process of being revamped, and this will be where the shop alkame.com domain will come into play. Everything that we've been doing up until this point has been preparing us for future growth. We've done no marketing or advertising, just tweaking our production equipment and getting better efficiencies, and all this will help us when we expand.
(MORE TO FOLLOW) Dow Jones Newswires
June 11, 2019 10:13 ET (14:13 GMT)
Alkame Holdings, Inc. Corporate Update -2-
Starting out with a small handful of clients when we started, we now have many customers, including those that are currently co-branded with the "Powered by Alkame Technology", and just under 75 new potential partners in various stages of discussion and development. All our subsidiaries walk a fine line regarding the dissemination of our client's information. We must abide by our non-disclosure agreements and are not permitted to divulge or announce customer plans or strategies. ANY disclosure on our part would be a breach of contract and open the possibility of legal actions. In addition, as a co-packer, many clients do not want it known that we are developing or producing products for them. We have built a solid relationship with our clients and have helped develop and pioneer new products right alongside of them. With all that said, we're very excited for a friend and client of ours who we assisted all the way from concept to their current success - Hemp Lifestyle. This brand not only has signed a multi-year Co-pack Agreement with us, but they themselves have just signed a landmark distribution contract covering four states and 7,000 stores. Way to Go!!
We have been slowly phasing out the imported vegetable private label business. We believe in being a well-rounded and diversified Company. We will be exploring an opportunity to pack Cherry's for export, similar to what we already do for Blueberries. Lot's more coming from Bell, so stay Tuned!
Alkame Holdings, Inc. continues to press forward with getting all filings out in sequential order, while continuing to stay strategically quiet. We are staying focused on fundamentals and building the businesses that we believe will carry us long into the future. We continue to hear from shareholders they want updates and news to come out on a more regular basis from the Company. However, on the advice of counsel and our advisers, we feel it is in the best interest of the Company to stay quiet until we are current with our filings, at which time the Caveat Emptor would be removed. The only thing holding the Company back and allowing us to grow faster are its capital constraints.
While there have been minor disputes with vendors, we expect to have these matters resolved over the next couple of months.
The Company has experienced several strains on its financial situation since funding was not available when most needed due to the delayed filing. However, due to our last filing being so delayed, and with a funding tied to that filing, the capital infusion did not occur as planned and has affected the projected numbers as we need to front load supplies for clients. We are certainly not out of the woods just yet. We were on track to hit a projected six million in revenue, but until the caveat emptier is removed the company will continue to have financial constraints and it will create financial headaches. We have been approached in the past by accredited investors who are or were shareholders and have offered funds as an alternative investment to assist the company. These investments were used as revolving equity lines of credit and or straight loans and repaid out of cash flow until the company can obtain capital from traditional financing sources after we are current.
Despite the Caveat Emptor, we are happy to report that since our last update we obtained our first traditional financing. In the latter part of the year 2018, we received a traditional revolving line of credit with extremely favorable terms. We are now in discussions about increasing the line. We are also proud to say that we are in talks for additional substantial lines of credit, as well as obtaining a purchase order financing group to assist in the front loading of materials when needed. It is still our goal and intention to pay off and retire some of our older notes that we had taken in the past out of cash flow generated. We are still on actively seeking out these types of supportive investors for discussion as we turn the corner, allowing us to grow faster and continue to provide positive corporate updates.
Recently we have received several investor inquiries asking if we are currently in merger and acquisition talks. We have been approached by multiple groups. However, as mentioned in our previous update we will not consider or entertain such talks at these low stock price levels and there is nothing to talk about or even consider until we are current in our filings. Lastly on this topic, our only focus is to get current and build the company, reduce debt, and increase revenues.
We continually seek out and entertain joint ventures or the sale of various brands that we own as we realize we cannot do it all ourselves. We can provide our technical know-how and assistance but there are many different avenues that we could enter into with the right partners and are actively seeking out those partnerships. We currently seek out and have opportunities available for our own brands, and several we plan on bringing to market shortly.
Lastly, we're proud to announce that we have a new brand that we will be launching shortly and introducing our very first product category with several SKU's for beta testing within the upcoming weeks. The brand is called "Cannarribean" and will hopefully be in the market in the next 6 to 8 weeks, we are making some final tweaks to artwork, and preparing a focus group on flavor testing, etc. We feel this brand has vast appeal and will be able to go into multiple different food and beverage categories within the CBD, hemp and THC space. Initial product launch will be online and then hopefully find the proper distribution partners to assist in a retail presence.
Alkame Holdings, Inc. wants to thank all our employees and stockholders, for your support as we continue to transform our Company into a powerhouse. Get ready for blueberry season! These are exciting times. STAY TUNED.
Sincerely,
Robert Eakle, CEO"
About Alkame Holdings, Inc.
Alkame Holdings, Inc. (OTC: ALKM) is a publicly traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. Through the Company's wholly owned subsidiary, Bell Food & Beverage Inc., a developer, manufacturer, and marketer of a variety of liquid based consumer products, such as condiments, sauces, syrups, waters, salsas, honeys, drink mixes, and a whole host of other products, with and without CBD, and utilizes the parent companies exclusive patented formula and technology for enhanced water with several unique properties as a base whenever possible. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications to utilize its Intellectual Property by placement into several emerging business sectors, such as the growing aqua-culture industry, consumer bottled water and RTD products, household pet products, horticulture and agriculture, and medical applications, as well as many other various water treatment solutions to both new and existing business platforms.
For more information, visit www.alkameholdingsinc.com.
Alkame Holdings, Inc. Investor Relations
Website: www.alkameholdingsinc.com
Email: info@alkameholdingsinc.com
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
SOURCE: Alkame Holdings, Inc.
View source version on accesswire.com:
https://www.accesswire.com/548417/Alkame-Holdings-Inc-Corporate-Update
View source version on accesswire.com:
https://www.accesswire.com/548417/Alkame-Holdings-Inc-Corporate-Update
> Dow Jones Newswires
June 11, 2019 10:13 ET (14:13 GMT)
Alkame Holdings, Inc. Corporate Update -2-
Starting out with a small handful of clients when we started, we now have many customers, including those that are currently co-branded with the "Powered by Alkame Technology", and just under 75 new potential partners in various stages of discussion and development. All our subsidiaries walk a fine line regarding the dissemination of our client's information. We must abide by our non-disclosure agreements and are not permitted to divulge or announce customer plans or strategies. ANY disclosure on our part would be a breach of contract and open the possibility of legal actions. In addition, as a co-packer, many clients do not want it known that we are developing or producing products for them. We have built a solid relationship with our clients and have helped develop and pioneer new products right alongside of them. With all that said, we're very excited for a friend and client of ours who we assisted all the way from concept to their current success - Hemp Lifestyle. This brand not only has signed a multi-year Co-pack Agreement with us, but they themselves have just signed a landmark distribution contract covering four states and 7,000 stores. Way to Go!!
We have been slowly phasing out the imported vegetable private label business. We believe in being a well-rounded and diversified Company. We will be exploring an opportunity to pack Cherry's for export, similar to what we already do for Blueberries. Lot's more coming from Bell, so stay Tuned!
Alkame Holdings, Inc. continues to press forward with getting all filings out in sequential order, while continuing to stay strategically quiet. We are staying focused on fundamentals and building the businesses that we believe will carry us long into the future. We continue to hear from shareholders they want updates and news to come out on a more regular basis from the Company. However, on the advice of counsel and our advisers, we feel it is in the best interest of the Company to stay quiet until we are current with our filings, at which time the Caveat Emptor would be removed. The only thing holding the Company back and allowing us to grow faster are its capital constraints.
While there have been minor disputes with vendors, we expect to have these matters resolved over the next couple of months.
The Company has experienced several strains on its financial situation since funding was not available when most needed due to the delayed filing. However, due to our last filing being so delayed, and with a funding tied to that filing, the capital infusion did not occur as planned and has affected the projected numbers as we need to front load supplies for clients. We are certainly not out of the woods just yet. We were on track to hit a projected six million in revenue, but until the caveat emptier is removed the company will continue to have financial constraints and it will create financial headaches. We have been approached in the past by accredited investors who are or were shareholders and have offered funds as an alternative investment to assist the company. These investments were used as revolving equity lines of credit and or straight loans and repaid out of cash flow until the company can obtain capital from traditional financing sources after we are current.
Despite the Caveat Emptor, we are happy to report that since our last update we obtained our first traditional financing. In the latter part of the year 2018, we received a traditional revolving line of credit with extremely favorable terms. We are now in discussions about increasing the line. We are also proud to say that we are in talks for additional substantial lines of credit, as well as obtaining a purchase order financing group to assist in the front loading of materials when needed. It is still our goal and intention to pay off and retire some of our older notes that we had taken in the past out of cash flow generated. We are still on actively seeking out these types of supportive investors for discussion as we turn the corner, allowing us to grow faster and continue to provide positive corporate updates.
Recently we have received several investor inquiries asking if we are currently in merger and acquisition talks. We have been approached by multiple groups. However, as mentioned in our previous update we will not consider or entertain such talks at these low stock price levels and there is nothing to talk about or even consider until we are current in our filings. Lastly on this topic, our only focus is to get current and build the company, reduce debt, and increase revenues.
We continually seek out and entertain joint ventures or the sale of various brands that we own as we realize we cannot do it all ourselves. We can provide our technical know-how and assistance but there are many different avenues that we could enter into with the right partners and are actively seeking out those partnerships. We currently seek out and have opportunities available for our own brands, and several we plan on bringing to market shortly.
Lastly, we're proud to announce that we have a new brand that we will be launching shortly and introducing our very first product category with several SKU's for beta testing within the upcoming weeks. The brand is called "Cannarribean" and will hopefully be in the market in the next 6 to 8 weeks, we are making some final tweaks to artwork, and preparing a focus group on flavor testing, etc. We feel this brand has vast appeal and will be able to go into multiple different food and beverage categories within the CBD, hemp and THC space. Initial product launch will be online and then hopefully find the proper distribution partners to assist in a retail presence.
Alkame Holdings, Inc. wants to thank all our employees and stockholders, for your support as we continue to transform our Company into a powerhouse. Get ready for blueberry season! These are exciting times. STAY TUNED.
Sincerely,
Robert Eakle, CEO"
About Alkame Holdings, Inc.
Alkame Holdings, Inc. (OTC: ALKM) is a publicly traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. Through the Company's wholly owned subsidiary, Bell Food & Beverage Inc., a developer, manufacturer, and marketer of a variety of liquid based consumer products, such as condiments, sauces, syrups, waters, salsas, honeys, drink mixes, and a whole host of other products, with and without CBD, and utilizes the parent companies exclusive patented formula and technology for enhanced water with several unique properties as a base whenever possible. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications to utilize its Intellectual Property by placement into several emerging business sectors, such as the growing aqua-culture industry, consumer bottled water and RTD products, household pet products, horticulture and agriculture, and medical applications, as well as many other various water treatment solutions to both new and existing business platforms.
For more information, visit www.alkameholdingsinc.com.
Alkame Holdings, Inc. Investor Relations
Website: www.alkameholdingsinc.com
Email: info@alkameholdingsinc.com
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
SOURCE: Alkame Holdings, Inc.
View source version on accesswire.com:
https://www.accesswire.com/548417/Alkame-Holdings-Inc-Corporate-Update
View source version on accesswire.com:
https://www.accesswire.com/548417/Alkame-Holdings-Inc-Corporate-Update
> Dow Jones Newswires
June 11, 2019 10:13 ET (14:13 GMT)
Banteks Drone USA Awarded Drone Contract by New Haven County Connecticut Police Department
8:34 AM ET 6/10/19 | Dow Jones
First Order from Recently Signed Distribution Deal with Drones by US
PINE BROOK, NJ / ACCESSWIRE / June 10, 2019 / Bantek, Inc. (OTC PINK: BANT) ("Bantek" or the "Company"), a distributor of products to the U.S. Government, an environmental services provider and reseller of drones and drone training, today announced that its Drone USA subsidiary has been awarded a contract to supply drones to a New Haven County, Connecticut Police Department.
Michael Bannon, Bantek's Chief Executive Officer, commented, "This is our first new contract as a distributor of Drones by US and supports the need for small quiet drones that can fly indoors. The police department purchased the small drones to assist their officers when approaching dangerous situations. The officers launch the DBUS2 drone in under a minute to survey the potentially hostile location before putting themselves in harm's way. The police also purchased a drone with heat-seeking capabilities for search and rescue missions and apprehending fleeing suspects."
About Drones by US
Drones by US (DbUS) sources, markets and sells ultra high-performance and fun small unmanned aircraft systems (UAS). Consumer friendly with easy-to-use apps and flight controllers, they are compact for travel most anywhere. We employ cutting-edge technologies such as visual-inertial odometry navigation for greater accuracy in "follow me" tracking and obstacle avoidance along a flight path.
Our technology partner, High Great Innovation Technology Development Company, is a leading manufacturer of advanced small UAS. We are members of the Unmanned Aircraft Safety Team, an industry-FAA partnership committed to ensuring the safe operation of unmanned aircraft in the national airspace system. We're passionate about flight in all of its forms.
For additional information about Drones by US, please visit:
www.dronesbyus.com
About Bantek, Inc, Inc.
Bantek, Inc. (OTC: BANT), headquartered in Pine Brook, NJ., consists of three separate divisions. First, through Howco Distributing Co., we sell products primarily to the U.S. Department of Defense. Second, through Drone USA we sell drone programs, which consists of drones, training, COA's and waivers and other drone-related services, to law enforcement, firefighters, security companies, local, state and our US government. Third, we sell insulation jackets, slates, and insulation services to hospitals, universities, and manufacturers.
For additional information about Bantek, Inc. and its businesses, please visit:
www.bantekinc.com
www.droneusainc.com
www.howcodistributing.com
Forward-Looking Statements
Certain statements in this press release may be considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include projections of matters that affect revenue, operating expenses or net earnings; projections of growth; and assumptions relating to the foregoing. Such forward-looking statements are generally qualified by terms such as: "plans, "anticipates," "expects," "believes," or similar words. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or qualified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking information. These factors are discussed in greater detail in our Form 10 filed with the U.S. Securities and Exchange Commission.
Contact Information
IR@bantekinc.com
SOURCE: Drone USA, Inc.
View source version on accesswire.com:
https://www.accesswire.com/548188/Banteks-Drone-USA-Awarded-Drone-Contract-by-New-Haven-County-Connecticut-Police-Department
View source version on accesswire.com:
https://www.accesswire.com/548188/Banteks-Drone-USA-Awarded-Drone-Contract-by-New-Haven-County-Connecticut-Police-Department
> Dow Jones Newswires
June 10, 2019 08:34 ET (12:34 GMT)
CELZ #148 for Ya. Dr's working on keeping the female population satisfied is my stock.
CELZ Now #6 on the BB. :)
CELZ..Hold on to many facts all at once. LOL
CELZ Thanks facts Femcell is already selling. :)
ALKM Slap them 9's buddy and get this party started. LOL
I am Just happy to see a bid again. Go PHIL :)
We might of picked the wrong PHI. I bet their SP is higher than ours. :)
Sorry, I guess that is why it never showed up on Ihub or OTC Mks. LOL
Sorry, My bad.
I saw it on here. https://www.sec.gov/cgi-bin/browse-edgar?action=getcurrent
Look at the time and date stamp.
PHI INC (0000350403) (Filer)
8-K [html][text] Current report, items 8.01 and 9.01
Accession Number: 0001193125-19-166917 Act: 34 Size: 31 KB 2019-06-06
12:45:02
ALKM had to paint it to say it. LOL
Bad MoJo/Karma
ALKM 9's up.
ALKM Not working only 500k sells today and 14 mil buys. Work harder. :)
PHI INC (0000350403) (Filer)
8-K [html][text] Current report, items 8.01 and 9.01
Accession Number: 0001193125-19-166917 Act: 34 Size: 31 KB 2019-06-06
12:45:02
PHIL 8-K out
Alkame Holdings Shareholders on FB